BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11249592)

  • 1. Olamufloxacin. Hokuriku Seiyaku.
    Jiraskova N
    Curr Opin Investig Drugs; 2000 Sep; 1(1):31-4. PubMed ID: 11249592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pazufloxacin Toyama Chemical Co.
    Johnson AP
    Curr Opin Investig Drugs; 2000 Sep; 1(1):52-7. PubMed ID: 11249595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two new fluoroquinolones.
    Med Lett Drugs Ther; 1992 Jun; 34(872):58-60. PubMed ID: 1317502
    [No Abstract]   [Full Text] [Related]  

  • 4. Dalbavancin (Biosearch Italia/Versicor).
    Steiert M; Schmitz FJ
    Curr Opin Investig Drugs; 2002 Feb; 3(2):229-33. PubMed ID: 12020051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthesis and antibacterial activity of tricycic fluoroquinolones].
    Xiong WN; Wang EH
    Yao Xue Xue Bao; 1997 May; 32(5):347-52. PubMed ID: 11498869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balofloxacin Choongwae.
    Alksne L
    Curr Opin Investig Drugs; 2003 Feb; 4(2):224-9. PubMed ID: 12669387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
    Higa F; Arakaki N; Tateyama M; Koide M; Shinzato T; Kawakami K; Saito A
    J Antimicrob Chemother; 2003 Dec; 52(6):920-4. PubMed ID: 14613952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (Fluorocyclopropyl)quinolones. 2. Synthesis and Stereochemical structure-activity relationships of chiral 7-(7-amino-5-azaspiro[2.4]heptan-5-yl)-1-(2-fluorocyclopropyl)quinolone antibacterial agents.
    Kimura Y; Atarashi S; Kawakami K; Sato K; Hayakawa I
    J Med Chem; 1994 Sep; 37(20):3344-52. PubMed ID: 7932562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of toxicokinetic variables and arthropathic changes in juvenile rabbits after oral administration of an investigational fluoroquinolone, PD 117596.
    Johnson RJ; Black WD; Sigler RE; Baragi VM; Gough AW
    Am J Vet Res; 2000 Nov; 61(11):1396-402. PubMed ID: 11108186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro antibacterial activity of N-[5-(5-nitro-2-furyl)-1,3,4-thiadiazole-2-yl] piperazinyl quinolone derivatives.
    Foroumadi A; Ashraf-Askari R; Moshafi MH; Emami S; Zeynali A
    Pharmazie; 2003 Jun; 58(6):432-3. PubMed ID: 12857013
    [No Abstract]   [Full Text] [Related]  

  • 11. [Recent development in quinolone compounds antitumor quinolones].
    Yang YS; Zhao SR; Ji RY; Chen KX
    Yao Xue Xue Bao; 1998; 33(2):157-60. PubMed ID: 11938953
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of 7-[3-(1-aminoalkyl)pyrrolidinyl]- and 7-[3-1-aminocycloalkyl)pyrrolidinyl]-quinolone antibacterials.
    Kimura Y; Atarashi S; Takahashi M; Hayakawa I
    Chem Pharm Bull (Tokyo); 1994 Jul; 42(7):1442-54. PubMed ID: 7923467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZD-0892 AstraZeneca.
    Ohbayashi H
    Curr Opin Investig Drugs; 2000 Oct; 1(2):227-9. PubMed ID: 11249578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of antibacterial 4-quinolone-3-carboxylic acids and their derivatives. Part 2.
    Leysen DC; Zhang MQ; Haemers A; Bollaert W
    Pharmazie; 1991 Aug; 46(8):557-72. PubMed ID: 1665908
    [No Abstract]   [Full Text] [Related]  

  • 15. Gd-Tex Pharmacyclics Inc.
    Radford IR
    Curr Opin Investig Drugs; 2000 Dec; 1(4):524-8. PubMed ID: 11249709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.
    Ruiz J
    J Antimicrob Chemother; 2003 May; 51(5):1109-17. PubMed ID: 12697644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PNU-142731A Pharmacia.
    Dent G
    Curr Opin Investig Drugs; 2000 Dec; 1(4):449-51. PubMed ID: 11249698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of action of antimicrobials: focus on fluoroquinolones.
    Hooper DC
    Clin Infect Dis; 2001 Mar; 32 Suppl 1():S9-S15. PubMed ID: 11249823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temafloxacin: the pharmacokinetic profile of a new quinolone. A seminar-in-print.
    Clin Pharmacokinet; 1992; 22 Suppl 1():1-107. PubMed ID: 1319864
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lemofloxacin: antimicrobial ability and clinico-pharmacokinetic basis for use in urogenital infections].
    Iakovlev SV
    Urologiia; 2002; (1):11-4. PubMed ID: 11877963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.